EUVIMEDEUVIMED entdecken
Leitlinie

Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome

Oliver Firth, Philip Arnold iD, Andrew R Gennery, Robert Johnson, Sara Mele, Tracey Shackleton, John Grant-Casey, Theodora Foukaneli iD, Helen V New

Transfusion Medicine · 23.06.2026

DOI: 10.1111/tme.70095 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Transfusion Medicine, online erschienen am 23.06.2026. Verfasst von Oliver Firth und 8 weiteren Autor:innen. Beteiligte Einrichtung: NHS Blood and Transplant, Cambridge, UK. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transfusion‐associated graft‐versus‐host disease (Ta‐GvHD) is a rare, usually fatal complication of transfusing cellular components, prevented by irradiation. Congenital heart disease (CHD), particularly DiGeorge syndrome (del22q), may be associated with severe T‐cell immunodeficiency and Ta‐GvHD risk. British Society for Haematology guidelines (BSH, 2020) recommended targeted use of irradiated components for CHD based on immunological assessment; guideline adherence was unknown.

Objectives

To understand UK use of irradiated components for paediatric CHD surgery and barriers to BSH guideline implementation.

Methods

An electronic survey distributed to the 11 UK paediatric cardiothoracic surgical centres (January‐March 2024 inclusive).

Results

Of the 11 centres, 9 (82%) responded. Naïve T‐cell enumeration, the BSH recommended test, was available to 8/9 (89%), but used in 4/9 (44%). 4/9 (44%) and 5/9 (56%) centres were willing to provide non‐irradiated components to neonates and children >28 days of age. Of these, 1/4 (25%), 1/5 (20%), and 4/5 (80%) (for neonates, young children, and children from 2 years) required criteria additional to BSH guidelines. 8/9 (89%) centres reported ongoing barriers to guideline implementation, particularly challenges around pathway development and timely naïve T‐cell enumeration.

Conclusion

Overuse of irradiated components in surgery for patients with congenital heart disease is high: only 1/3 of paediatric cardiac centres adhered to BSH guidance. Reasons included difficulties in immunological diagnostic pathway development. Collaboration between paediatric cardiothoracic, transfusion and immunology teams is required to address this.

Autor:innen und Institutionen

  • NHS Blood and Transplant, Cambridge, UK.
  • Department of Anaesthesia, Alder Hey Children's Hospital, Liverpool, UK.
  • Department of Paediatric Immunology, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Department of Cardiology, Alder Hey Children's Hospital, Liverpool, UK.
  • Department of Anaesthesia, Royal Brompton Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Alder Hey Children's Hospital, Liverpool, UK.

ORCID-Profile: Philip Arnold, Theodora Foukaneli

Zitieren

APA

Firth, O., Arnold, P., Gennery, A. R., Johnson, R., Mele, S., Shackleton, T., Grant-Casey, J., Foukaneli, T., & New, H. V. (2026). Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome. Transfusion Medicine. https://doi.org/10.1111/tme.70095

Vancouver

Firth O, Arnold P, Gennery AR, Johnson R, Mele S, Shackleton T, et al. Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome. Transfusion Medicine. 2026. doi:10.1111/tme.70095

BibTeX
@article{Firth2026,
  author = {Firth, Oliver and Arnold, Philip and Gennery, Andrew R and Johnson, Robert and Mele, Sara and Shackleton, Tracey and Grant-Casey, John and Foukaneli, Theodora and New, Helen V},
  title = {Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome},
  journal = {Transfusion Medicine},
  year = {2026},
  doi = {10.1111/tme.70095}
}
Kostenlos starten →